| Functional Brain Connectivity Studies | Lifetime | 55 | CN 2 | 99.83 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 62 | CN 3 | 99.65 |
| Advanced MRI Techniques and Applications | Lifetime | 207 | CN 4 | 99.36 |
| Mental Health Research Topics | Lifetime | 148 | CN 1 | 99.12 |
| Nanoplatforms for cancer theranostics | Lifetime | 458 | CN 309 | 98.34 |
| Nanoparticle-Based Drug Delivery | Lifetime | 529 | CN 207 | 97.95 |
| Neural dynamics and brain function | Lifetime | 852 | CN 33 | 97.93 |
| Schizophrenia research and treatment | Lifetime | 756 | CN 10 | 97.67 |
| Traumatic Brain Injury Research | Lifetime | 458 | CN 3 | 96.79 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 512 | CN 4 | 96.56 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 760 | CN 17 | 94.14 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 655 | CN 4 | 94.84 |
| Treatment of Major Depression | Lifetime | 845 | CN 12 | 94.59 |
| Posttraumatic Stress Disorder Research | Lifetime | 887 | CN 11 | 91.56 |
| Functional Brain Connectivity Studies | 2021-2025 | 1 | CN 1 | 99.95 |
| Advanced Neuroimaging Techniques and Applications | 2021-2025 | 2 | CN 1 | 99.88 |
| Advanced MRI Techniques and Applications | 2021-2025 | 8 | CN 2 | 99.17 |
| Mental Health Research Topics | 2021-2025 | 13 | CN 2 | 99.46 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 93 | CN 39 | 97.96 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 268 | CN 232 | 98.13 |
| Neural dynamics and brain function | 2021-2025 | 191 | CN 59 | 97.20 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 226 | CN 100 | 94.34 |
| Tryptophan and brain disorders | 2021-2025 | 227 | CN 62 | 95.28 |
| Bipolar Disorder and Treatment | 2021-2025 | 122 | CN 5 | 95.70 |
| Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes | 2021-2025 | 137 | CN 5 | 94.39 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 377 | CN 31 | 92.80 |
| Treatment of Major Depression | 2021-2025 | 140 | CN 11 | 93.97 |
| Schizophrenia research and treatment | 2021-2025 | 388 | CN 27 | 93.17 |
| Epilepsy research and treatment | 2021-2025 | 443 | CN 34 | 92.86 |
| RNA Interference and Gene Delivery | 2021-2025 | 689 | CN 333 | 91.32 |
| Neural and Behavioral Psychology Studies | 2021-2025 | 393 | CN 33 | 90.15 |
| Attention Deficit Hyperactivity Disorder | 2021-2025 | 351 | CN 18 | 88.91 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 304 | CN 10 | 87.96 |
| Stress Responses and Cortisol | 2021-2025 | 839 | CN 102 | 83.76 |
| Traumatic Brain Injury Research | 2021-2025 | 768 | CN 23 | 85.27 |
| Dendrimers and Hyperbranched Polymers | 2021-2025 | 141 | CN 51 | 81.45 |
| Lanthanide and Transition Metal Complexes | 2021-2025 | 719 | CN 233 | 84.18 |
| Posttraumatic Stress Disorder Research | 2021-2025 | 924 | CN 34 | 71.97 |
| Traditional Chinese Medicine Studies | 2021-2025 | 756 | CN 550 | 57.11 |
